Edit
noodls22 Oct 2013
(Source. Orion Oyj). ORION CORPORATION / INTERIM REPORT / JANUARY-SEPTEMBER 2013 22 October 2013 at 12.00 noon EEST. Orion's net sales in January-September 2013 totalled EUR 734 million (EUR 726 million in January- September 2012) ... Equity ratio was 52% (59%). ... Orion's animal sedatives are Dexdomitor® (dexmedetomidine), Domitor® (medetomidine), Domosedan® (detomidine) and Antisedan® (atipamezole) ... b....(size: 71.2Kb)
Edit
noodls30 Jul 2013
(Source. Orion Oyj). ORION CORPORATION / INTERIM REPORT / JANUARY-JUNE 2013 / 30 July 2013 at 12.00 noon EEST. Orion's net sales in January-June 2013 totalled EUR 497 million (EUR 480 million in January-June 2012). Operating profit was EUR 135 (144) million. ... Orion's animal sedatives are Dexdomitor® (dexmedetomidine), Domitor® (medetomidine), Domosedan® (detomidine) and Antisedan® (atipamezole) ... b....(size: 70.4Kb)
Edit
noodls30 Apr 2013
(Source. Grindeks AS). 30.04.2013. Today, on 30 April, JSC «Grindeks» has submitted the audited consolidated financial statements for 2012 to "NASDAQ OMX Riga" ... In 2012, gross profit margin was 61.8%, whereas, net profit margin comprised 11.6% ... zopiclone, oxytocin, ftorafur (tegafur), UDCA (ursodeoxycholic acid), droperidol as well as the veterinary products - detomidine, medetomidine, atipamezole and pimobendane ... About «Grindeks» ... Phones....(size: 5.3Kb)
Edit
noodls01 Mar 2013
(Source. Grindeks AS). 28.02.2013. On 28 February, JSC «Grindeks» submitted the non-audited consolidated financial statements for 2012 to "NASDAQ OMXRiga" ... zopiclone, oxytocin, ftorafur (tegafur), UDCA (ursodeoxycholic acid), droperidol as well as the veterinary products - detomidine, medetomidine, atipamezole and pimobendane. Overall «Grindeks» produces 22 active pharmaceutical ingredients ... About «Grindeks» ... The main markets are....(size: 5.7Kb)
Edit
noodls05 Feb 2013
(Source. Orion Oyj) "Significant progress in Orion's research projects". "Our net sales were higher than in the previous year and our operating profit was similar to 2011 despite clearly higher research expenses ... This was the case in all the Nordic markets, for example ... Strategy ... Orion's animal sedatives are Dexdomitor® (dexmedetomidine), Domitor® (medetomidine), Domosedan® (detomidine) and Antisedan® (atipamezole)....(size: 141.9Kb)
Edit
noodls23 Oct 2012
ORION CORPORATION / INTERIM REPORT / JANUARY-SEPTEMBER 2012 / 23 October 2012 at 12.00 noon EEST. Orion's net sales for January-September 2012 totalled EUR 726 million (EUR 682 million for January-September 2011), up by 7% on the comparative period last year ... Events during the period ... Orion's animal sedatives are Dexdomitor® (dexmedetomidine), Domitor® (medetomidine), Domosedan® (detomidine) and Antisedan® (atipamezole). Fermion....(size: 143.7Kb)
Edit
noodls31 Jul 2012
ORION CORPORATION / INTERIM REPORT / JANUARY-JUNE 2012 / 31 JULY 2012 at 12.00 noon EEST. Orion's net sales for January-June 2012 totalled EUR 480 million (EUR 471 million for January-June 2011), up by 2% on the comparative period last year. Operating profit was EUR 145 (158) million. ... Net sales ... Orion's animal sedatives are Dexdomitor® (dexmedetomidine), Domitor® (medetomidine), Domosedan® (detomidine) and Antisedan® (atipamezole)....(size: 140.2Kb)
